BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8336942)

  • 41. Transcriptional activation domains of elk-1, delta elk-1 and SAP-1 proteins.
    Bhattacharya G; Lee L; Reddy ES; Rao VN
    Oncogene; 1993 Dec; 8(12):3459-64. PubMed ID: 8247551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
    Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
    Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells.
    Kwiatkowski BA; Zielinska-Kwiatkowska AG; Bauer TR; Hickstein DD
    Blood Cells Mol Dis; 2000 Feb; 26(1):84-90. PubMed ID: 10772879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SRE elements are binding sites for the fusion protein EWS-FLI-1.
    Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
    Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fli-1 (Friend leukemia integration 1). Oncogene].
    Bull Cancer; 1998 Oct; 85(10):830. PubMed ID: 9867365
    [No Abstract]   [Full Text] [Related]  

  • 47. Structural comparison of the PhoB and OmpR DNA-binding/transactivation domains and the arrangement of PhoB molecules on the phosphate box.
    Okamura H; Hanaoka S; Nagadoi A; Makino K; Nishimura Y
    J Mol Biol; 2000 Feb; 295(5):1225-36. PubMed ID: 10653699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
    Ben-David Y; Giddens EB; Letwin K; Bernstein A
    Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
    Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
    Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
    Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
    Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. elk-1 domains responsible for autonomous DNA binding, SRE:SRF interaction and negative regulation of DNA binding.
    Rao VN; Reddy ES
    Oncogene; 1992 Nov; 7(11):2335-40. PubMed ID: 1437156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
    Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
    Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
    May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
    Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein.
    Gegonne A; Punyammalee B; Rabault B; Bosselut R; Seneca S; Crabeel M; Ghysdael J
    New Biol; 1992 May; 4(5):512-9. PubMed ID: 1515415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional dissection of the transcription factor Elk-1.
    Janknecht R; Zinck R; Ernst WH; Nordheim A
    Oncogene; 1994 Apr; 9(4):1273-8. PubMed ID: 8134131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
    Reddy ES; Rao VN
    Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutant screening for oncogenes of Ewing's sarcoma using yeast.
    Kitagawa T; Okita H; Baron B; Tokuda K; Nakamura M; Wang Y; Akada J; Hoshida H; Akada R; Kuramitsu Y; Nakamura K
    Appl Microbiol Biotechnol; 2015 Aug; 99(16):6737-44. PubMed ID: 25936378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.
    Mavrothalassitis G; Fisher RJ; Smyth F; Watson DK; Papas TS
    Oncogene; 1994 Feb; 9(2):425-35. PubMed ID: 8290254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.
    Darby TG; Meissner JD; Rühlmann A; Mueller WH; Scheibe RJ
    Oncogene; 1997 Dec; 15(25):3067-82. PubMed ID: 9444955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.